Wealthfront Advisers’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$543K Buy
915
+140
+18% +$69.7K ﹤0.01% 817
2025
Q4
$378K Sell
775
-14
-2% -$6.52K ﹤0.01% 876
2025
Q3
$331K Sell
789
-64
-8% -$21.5K ﹤0.01% 887
2025
Q2
$245K Sell
853
-6
-0.7% -$1.79K ﹤0.01% 910
2025
Q1
$265K Sell
859
-26
-3% -$8.91K ﹤0.01% 863
2024
Q4
$312K Buy
885
+9
+1% +$3.31K ﹤0.01% 830
2024
Q3
$314K Sell
876
-29
-3% -$9.8K ﹤0.01% 828
2024
Q2
$288K Buy
+905
New +$240K ﹤0.01% 816
2023
Q1
Sell
-795
Closed -$221K 821
2022
Q4
$221K Buy
+795
New +$201K ﹤0.01% 760
2022
Q1
Sell
-1,261
Closed -$272K 818
2021
Q4
$272K Buy
1,261
+172
+16% +$33.8K ﹤0.01% 698
2021
Q3
$201K Buy
+1,089
New +$215K ﹤0.01% 687

Other funds holding UTHR